Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RecoMed is an active digital health company based in Cape Town, South Africa. It operates the country’s largest online healthcare marketplace where patients can find practitioners and book both physical and virtual appointments. Founded by Sheraan Amod after identifying a gap in digital medical bookings upon returning from the US to South Africa, RecoMed has become integral to patient-provider connectivity across the region. The company was an early adopter of telehealth technology before COVID‑19 made such platforms essential infrastructure. Its business model charges providers per booking generated via its site/app. Major partnerships include work with Discovery Health and Mediclinic on mass vaccination efforts during the pandemic period. In late 2021 it raised $1.5M led by Vunani Fintech Fund to expand into integrated payments/e-pharmacy services[1][2]. There are no drug development programs or biotech/pharma pipelines associated with this entity—it serves as a technology-enabled facilitator within broader primary care/vaccination delivery rather than as a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RecoMed.